Aurintricarboxylic acid
(Synonyms: 金精三羧酸) 目录号 : GC39699A protein synthesis inhibitor with diverse biological activities
Cas No.:4431-00-9
Sample solution is provided at 25 µL, 10mM.
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
Aurintricarboxylic acid (ATA) is an inhibitor of protein synthesis that has diverse biological activities.1,2,3,4,5,6,7,8 It inhibits the activity of a variety of enzymes, including the nucleases DNase I, RNase A, and S1, as well as the serine proteases trypsin and chymotrypsin in a concentration-dependent manner.2,3 ATA inhibits replication of severe acute respiratory syndrome coronavirus (SARS-CoV; EC50 = 200 ?g/ml) and human enterovirus 71 in Vero cells (EV71; EC50 = 2.9 ?M), as well as reduces HIV-1- or HIV-2-induced cytopathogenicity in MT-4 cells (IC50s = 1.1 and 0.85 ?g/ml, respectively).4,5,6 It inhibits apoptosis induced by sanguinarine in K562 leukemia cells when used at a concentration of 100 ?M.7 ATA (20 mg/kg, i.p.) decreases CNS CD4+ T cell infiltration and reduces hind limb weakness and paralysis in a mouse model of myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis (EAE).8
1.Siegelman, F., and Apirion, D.Aurintricarboxylic acid, a preferential inhibitor of initiation of protein synthesisJ. Bacteriol.105(3)902-907(1971) 2.Hallick, R.B., Chelm, B.K., Gray, P.W., et al.Use of aurintricarboxylic acid as an inhibitor of nucleases during nucleic acid isolationNucleic Acids Res.4(9)3055-3064(1977) 3.Bina-Stein, M., and Tritton, T.R.Aurintricarboxylic acid is a nonspecific enzyme inhibitorMol. Pharmacol.12(1)191-193(1976) 4.He, R., Adonov, A., Traykova-Adonova, M., et al.Potent and selective inhibition of SARS coronavirus replication by aurintricarboxylic acidBiochem. Biophys. Res. Commun.320(4)1199-1203(2004) 5.Hung, H.-C., Chen, T.-C., Fang, M.-Y., et al.Inhibition of enterovirus 71 replication and the viral 3D polymerase by aurintricarboxylic acidJ. Antimicrob. Chemother.65(4)676-683(2010) 6.Cushman, M., Wang, P.L., Chang, S.H., et al.Preparation and anti-HIV activities of aurintricarboxylic acid fractions and analogues: Direct correlation of antiviral potency with molecular weightJ. Med. Chem.34(1)329-337(1991) 7.Hallock, S., Tang, S.-C., Buja, L.M., et al.Aurintricarboxylic acid inhibits protein synthesis independent, sanguinarine-induced apoptosis and oncosisToxicol. Pathol.35(2)300-309(2007) 8.Zhang, F., Wei, W., Chai, H., et al.Aurintricarboxylic acid ameliorates experimental autoimmune encephalomyelitis by blocking chemokine-mediated pathogenic cell migration and infiltrationJ. Immunol.190(3)1017-1025(2013)
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 2.3678 mL | 11.8388 mL | 23.6776 mL |
5 mM | 0.4736 mL | 2.3678 mL | 4.7355 mL |
10 mM | 0.2368 mL | 1.1839 mL | 2.3678 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。